Ellis, Anne K.
Gagnon, RĂ©mi
Hammerby, Eva http://orcid.org/0000-0001-9418-264X
Shen, Julia
Gosain, Sheena
Article History
Received: 18 February 2021
Accepted: 23 June 2021
First Online: 8 July 2021
Declarations
:
: Ethical clearance and consent to participate are not applicable to this article.
: Not applicable. No individual patient data is provided.
: AKE (over her lifetime) has participated in advisory boards for Abbvie, ALK-Abello, Aralez, Circassia Ltd, GlaxoSmithKline, LEO Pharma, Merck, Mylan, Novartis, Pediapharm, Pfizer and Sanofi and has been a speaker for ALK-Abello, Aralez, AstraZeneca, Boehringer Ingelheim, Meda, Medexus, Merck, Mylan, Novartis, Pediapharm, Pfizer, and Takeda. Her institution has received research grants from ALK Abello, Aralez, AstraZeneca, Bayer, Circassia Ltd, Green Cross Pharmaceuticals, GlaxoSmithKline, Medexus, Sun Pharma, Merck, Novartis, Pfizer, Regeneron and Sanofi. AKE is also a former consultant to ALK-Abello Canada and Bayer Consumer Health Division.EH is an employee of ALK-Abello.JS and SG are employees of PDCI, and PDCI has performed consulting work for ALK-Abello.RG has participated in advisory boards for ALK-Abello, GlaxoSmithKline, Merck, Novartis, Pediapharm, Pfizer, AstraZeneca, Aralez, Shire, CSL Behring and Sanofi and has been a speaker for ALK-Abello, Aralez, AstraZeneca, Merck, Novartis, Pediapharm and Pfizer. RG is also involved in clinical trials with Green Cross Pharmaceuticals, GlaxoSmithKline, Merck, Novartis, AstraZeneca, DBV, Regeneron, Stallergenes, Shire, Biocryst and Sanofi.